← Open Payments lookup

JESSICA SMITH: Open Payments

NPI 1699081620 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,128 in 101 payments from 24 companies in 2025. Trend: 2023 $1,468 · 2024 $1,956 · 2025 $2,128

Food & beverage: $2,128
CompanyPaymentsAmount
Novo Nordisk Inc12$308
ABBVIE INC.18$214
Lilly USA, LLC12$213
Astellas Pharma US Inc6$201
AstraZeneca Pharmaceuticals LP10$201
GlaxoSmithKline, LLC.8$137
Insulet Corporation1$127
Dexcom, Inc.5$114
Inspire Medical Systems, Inc.1$101
Boehringer Ingelheim Pharmaceuticals, Inc.6$93

Products named: Ozempic, Veozah, MOUNJARO, AIRSUPRA, JARDIANCE, OMNIPOD, Dexcom G6 Transmitter, TRELEGY ELLIPTA.

Industry payments across LA — which companies pay providers there.